Novartis AG (ADR)  

(Public, NYSE:NVS)   Watch this stock  
Find more results for NVS
100.22
+0.21 (0.21%)
Real-time:   10:06AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 99.62 - 100.32
52 week 80.64 - 103.50
Open 99.82
Vol / Avg. 195,812.00/2.66M
Mkt cap 270.89B
P/E 23.16
Div/yield 2.82/2.81
EPS 4.33
Shares 2.40B
Beta 0.53
Inst. own 10%
Apr 23, 2015
Q1 2015 Novartis AG Earnings Release - 3:00AM EDT - Add to calendar
Mar 4, 2015
Novartis AG at Credit Suisse Global Healthcare Conference - 3:40AM EST - Add to calendar
Mar 4, 2015
Novartis AG at Cowen Health Care Conference Add to calendar
Feb 27, 2015
Novartis AG Annual Shareholders Meeting - Webcast
Feb 12, 2015
Novartis AG at Leerink Global Healthcare Conference
Jan 27, 2015
Q4 2014 Novartis AG Earnings Call - Webcast
Jan 27, 2015
Q4 2014 Novartis AG Earnings Press Conference
Jan 27, 2015
Q4 2014 Novartis AG Earnings Release
Jan 12, 2015
Novartis AG at JPMorgan Healthcare Conference - Q&A Session
Jan 12, 2015
Novartis AG at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 18.33% 20.00%
Operating margin 17.61% 20.68%
EBITD margin - 31.46%
Return on average assets 7.83% 8.53%
Return on average equity 13.84% 14.69%
Employees 133,413 -
CDP Score - 94 B

Address

Lichtstrasse 35
BASEL, 4056
Switzerland
+41-61-6969511 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools ans over-the-counter products. It has four operating segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics; and consumer health, which include over-the-counter medicines (OTC).

Officers and directors

Joerg Reinhardt Ph.D. Chairman of the Board
Age: 59
Bio & Compensation  - Reuters
Joseph S. Jimenez Chief Executive Officer, Member of the Executive Committee
Age: 54
Bio & Compensation  - Reuters
Ulrich Lehner Vice Chairman of the Board of Directors, Non-Executive Director
Age: 68
Bio & Compensation  - Reuters
Harry Kirsch Chief Financial Officer, Member of the Executive Committee
Age: 49
Bio & Compensation  - Reuters
Peter Kornicker Chief Compliance Officer
Bio & Compensation  - Reuters
Felix R. Ehrat Ph.D. Group General Counsel, Member of the Executive Committee
Age: 58
Bio & Compensation  - Reuters
Steven Baert Head Human Resources and Member of the Executive Committee
Age: 40
Bio & Compensation  - Reuters
Michele Galen Head Communications
Bio & Compensation  - Reuters
Paul van Arkel Head of Corporate Strategy and External Affairs
Bio & Compensation  - Reuters
Erwin Vanhaecke Ph.D. Head Novartis Group Quality
Bio & Compensation  - Reuters